ホームMCPワークベンチSkills
ホームワークベンチ通知マイページ
llms.txt · MCPガイドプライバシーポリシー · 利用規約 · サポートv1.8.3
  1. ホーム
  2. /反応

2-Dimethylaminopyridine → HCID 178499660、化合物

HRID 270981
印刷

反応式

HRID 270981 の反応式
[CH:1]1([C:7]2[C:12](=[O:13])[N:11]3[N:14]=[C:15]([C:17](O)=[O:18])[CH:16]=[C:10]3[NH:9][C:8]=2[C:20]2[O:21][CH:22]=[CH:23][CH:24]=2)[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]1.[CH:25]([N:28]([CH:31]([CH3:33])[CH3:32])CC)([CH3:27])[CH3:26].CN([C:37]1[CH:42]=[CH:41]C=CN=1)C.Cl.[CH3:44][O:45][C:46](=[O:59])[C@H:47](CC1C2C(=CC=CC=2)NC=1)[NH2:48].CN(C(ON1N=NC2C=CC=NC1=2)=[N+](C)C)C.F[P-](F)(F)(F)(F)F>CN(C)C=O.C(OCC)(=O)C>[CH3:44][O:45][C:46](=[O:59])[CH:47]([NH:48][C:17]([C:15]1[CH:16]=[C:10]2[NH:9][C:8]([C:20]3[O:21][CH:22]=[CH:23][CH:24]=3)=[C:7]([CH:1]3[CH2:6][CH2:5][CH2:4][CH2:3][CH2:2]3)[C:12](=[O:13])[N:11]2[N:14]=1)=[O:18])[CH2:33][C:31]1[NH:28][C:25]2[C:26]([CH:32]=1)=[CH:41][CH:42]=[CH:37][CH:27]=2
参加物実験手順後処理出典と根拠反応ノート

参加物

8

反応物 5

HCID 218852-DimethylaminopyridineHCID 81531DiisopropylethylamineHCID 2734891Methyl tryptophanate hydrochlorideHCID 9886157Methanaminium, N-((dimethylamino)(3H-1,2,3-triazolo(4,5-b)pyridin-3-yloxy)methylene)-N-methyl-, hexafluorophosphate(1-) (1:1)HCID 178524066HCID 178524066、化合物

生成物 1

HCID 178499660
HCID 178499660、化合物
収率 39%

試薬・触媒・溶媒 2

HCID 6228Dimethylformamide溶媒HCID 8857Ethyl Acetate溶媒

実験手順

To a solution of 8.2 mg (0.025 mmol) of 6-cyclohexyl-5-furan-2-yl-7-oxo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-2-carboxylic acid in 2 mL of dimethylformamide (DMF) was added 0.009 mL (0.05 mmol) of diisopropylethylamine (DIEA), a few crystals of dimethylaminopyridine (DMAP cat), 7 mg (0.027 mmol) of L-tryptophan methyl ester hydrochloride, followed by 11 mg (0.03 mmol) of HATU, and the resulting mixture was stirred at rt overnight. The reaction mixture was diluted with ethyl acetate, washed with 0.1 N sodium hydroxide solution (2 times) and brine. The separated organic layer was dried over sodium sulfate and concentrated to give a residue which was purified via reverse-phase chromatography (Gilson) to afford desired 2-[(6-cyclohexyl-5-furan-2-yl-7-oxo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-2-carbonyl)-amino]-3-(1H-indol-2-yl)-propionic acid methyl ester (606). This compound was then converted to 2-[(6-cyclohexyl-5-furan-2-yl-7-oxo-4,7-dihydro-pyrazolo[1,5-a]pyrimidine-2-carbonyl)-amino]-3-(1H-indol-2-yl)-propionic acid (599) via the well known LiOH saponification protocol (39% yield over 2 steps); LC-MS calcd. for C28H27N5O5 [M++H]+: 514.2; found: 514.2.

後処理

  1. washwashed with 0.1 N sodium hydroxide solution (2 times) and brine
  2. dry with materialThe separated organic layer was dried over sodium sulfate
  3. concentrationconcentrated
  4. customto give a residue which
  5. customwas purified via reverse-phase chromatography (Gilson)

出典と根拠

ORDレコード
ord-d36a53c591ec47bcb8961df05fadeaf7
出典データセット
uspto-grants-2008_11
DOI
10.6084/m9.figshare.5104873.v1
特許番号
US07449488B2

反応ノート

このページの内容参加物実験手順後処理出典と根拠反応ノート